• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsPolaris AI Pharma
    Picture of Polaris AI Pharma logo

    041910 — Polaris AI Pharma Share News

    KR₩5,6900.000.00%
    kr flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      KR₩76bn
    • Enterprise Value
      KR₩70bn
    • Revenue
      KR₩56bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 041910 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    041910 Dividends
    • Brief: Polaris Ai Pharma To Cancel 2 Billion Won Worth Of Own Shares

      19/03/2026 09:43
    • Brief: Polaris Ai Pharma To Acquire Real Estate Worth 73 Billion Won

      07/07/2025 09:35
    • Brief: Polaris Ai Pharma To Conduct Capital Increase Of 5 Billion Won For Operational Funds

      25/09/2024 09:14
    • Brief: EstechPharma to pay annual dividend as 50 won/share for FY 2016

      09/02/2017 05:07
    • Brief: Innopharmax cancels contract worth 3.58 bln won with Estechpharma

      30/11/2016 06:28
    • Brief: Innopharmax cancels 49.27 bln won worth of contract with Estechpharma

      30/11/2016 06:14
    • Brief: Insight Agents cancels 7.68 bln won worth contract with EstechPharma

      02/11/2016 07:08

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.